{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:52:36Z","timestamp":1791503556357,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.mcna.2021.08.012","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T21:58:58Z","timestamp":1637618338000},"page":"113-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Benzodiazepines and Related Sedatives"],"prefix":"10.1016","volume":"106","author":[{"given":"Linda","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Morford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximena A.","family":"Levander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.mcna.2021.08.012_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0740-5472(91)90027-8","article-title":"History of benzodiazepine dependence","volume":"8","author":"Lader","year":"1991","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.012_bib2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMp1715050","article-title":"Our other prescription drug problem","volume":"378","author":"Lembke","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.012_bib3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1176\/appi.ps.201800321","article-title":"Benzodiazepine use and misuse among adults in the United States","volume":"70","author":"Maust","year":"2019","journal-title":"Psychiatr Serv"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.012_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.addbeh.2008.10.021","article-title":"Early-onset drug use and risk for drug dependence problems","volume":"34","author":"Chen","year":"2009","journal-title":"Addict Behav"},{"key":"10.1016\/j.mcna.2021.08.012_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.mcna.2021.08.012_bib7","series-title":"FDA requiring boxed warning updated to improve safe use of benzodiazepine drug class","year":"2020"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.012_bib8","doi-asserted-by":"crossref","first-page":"e202361","DOI":"10.1001\/jamanetworkopen.2020.2361","article-title":"Alcohol or benzodiazepine co-involvement with opioid overdose deaths in the United States, 1999-2017","volume":"3","author":"Tori","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.012_bib9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amepre.2015.03.040","article-title":"Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines","volume":"49","author":"Jones","year":"2015","journal-title":"Am J Prev Med"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1124\/pr.117.014381","article-title":"Drugs for insomnia beyond benzodiazepines: pharmacology, clinical applications, and discovery","volume":"70","author":"Atkin","year":"2018","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.012_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/ijnp\/pyz007","article-title":"An insight into Z-drug abuse and dependence: an examination of reports to the European Medicines Agency Database of suspected adverse drug reactions","volume":"22","author":"Schifano","year":"2019","journal-title":"Int J Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.012_bib12","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.psym.2019.02.007","article-title":"Novel ways to acquire designer benzodiazepines: a case report and discussion of the changing role of the internet","volume":"60","author":"Shapiro","year":"2019","journal-title":"Psychosomatics"},{"key":"10.1016\/j.mcna.2021.08.012_bib13","series-title":"The misuse of benzodiazepines among high-risk opioid users in Europe","year":"2018"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.012_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/15563650.2018.1510502","article-title":"Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014-2017","volume":"57","author":"Carpenter","year":"2019","journal-title":"Clin Toxicol"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.012_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.annemergmed.2014.12.019","article-title":"Overdose of etizolam: the abuse and rise of a benzodiazepine analog","volume":"65","author":"O'Connell","year":"2015","journal-title":"Ann Emerg Med"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.012_bib17","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","article-title":"The benzodiazepine binding sites of GABAA receptors","volume":"39","author":"Sigel","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.012_bib18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.tips.2018.04.003","article-title":"An emerging circuit pharmacology of GABAA receptors","volume":"39","author":"Engin","year":"2018","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib19","first-page":"144","article-title":"Alcohol and neurotransmitter interactions","volume":"21","author":"Valenzuela","year":"1997","journal-title":"Alcohol Health Res World"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib20","first-page":"214","article-title":"Benzodiazepine pharmacology and central nervous system-mediated effects","volume":"13","author":"Griffin","year":"2013","journal-title":"Ochsner J"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.012_bib21","first-page":"4","article-title":"A\u00a0review of alprazolam use, misuse, and withdrawal","volume":"12","author":"Ait-Daoud","year":"2018","journal-title":"J\u00a0Addict Med"},{"issue":"9","key":"10.1016\/j.mcna.2021.08.012_bib22","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/0269881119901096","article-title":"Designer benzodiazepines' pharmacological effects and potencies: how to find the information","volume":"34","author":"El Balkhi","year":"2020","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.mcna.2021.08.012_bib23","author":"Ashton"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib24","first-page":"20","article-title":"Benzodiazepines II: waking up on sedatives: providing optimal care when inheriting benzodiazepine prescriptions in transfer patients","volume":"7","author":"Guina","year":"2018","journal-title":"J\u00a0Clin Med Res"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib25","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13181-013-0292-0","article-title":"The clinical and forensic toxicology of Z-drugs","volume":"9","author":"Gunja","year":"2013","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.mcna.2021.08.012_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuro.2019.02.015","article-title":"An expanding world of new psychoactive substances-designer benzodiazepines","volume":"73","author":"Zawilska","year":"2019","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.mcna.2021.08.012_bib27","series-title":"The ASAM principles of addiction medicine","first-page":"797","author":"Miller","year":"2018"},{"issue":"12","key":"10.1016\/j.mcna.2021.08.012_bib28","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1056\/NEJMra1611832","article-title":"Treatment of benzodiazepine dependence","volume":"376","author":"Soyka","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.012_bib29","first-page":"33","article-title":"Urine drug tests: ordering and interpreting results","volume":"99","author":"Kale","year":"2019","journal-title":"Am Fam Physician"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.012_bib30","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/dta.2003","article-title":"Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays","volume":"9","author":"Pettersson Bergstrand","year":"2017","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.mcna.2021.08.012_bib31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jchromb.2016.08.047","article-title":"Development and application of a multi-component LC-MS\/MS method for determination of designer benzodiazepines in urine","volume":"1035","author":"Pettersson Bergstrand","year":"2016","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"7103","key":"10.1016\/j.mcna.2021.08.012_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1136\/bmj.315.7103.297","article-title":"ABC of mental health. Addiction and dependence--I: illicit drugs","volume":"315","author":"Gerada","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/j.1552-4604.1985.tb02811.x","article-title":"Rebound insomnia and elimination half-life: assessment of individual subject response","volume":"25","author":"Bixler","year":"1985","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.012_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/00952998209002608","article-title":"Benzodiazepine withdrawal syndrome: a literature review and evaluation","volume":"9","author":"MacKinnon","year":"1982","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"11","key":"10.1016\/j.mcna.2021.08.012_bib35","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1360-0443.1994.tb03743.x","article-title":"The benzodiazepine withdrawal syndrome","volume":"89","author":"P\u00e9tursson","year":"1994","journal-title":"Addiction"},{"issue":"1\u20132","key":"10.1016\/j.mcna.2021.08.012_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0740-5472(91)90023-4","article-title":"Protracted withdrawal syndromes from benzodiazepines","volume":"8","author":"Ashton","year":"1991","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.31887\/DCNS.2017.19.2\/fthibaut","article-title":"Anxiety disorders: a review of current literature","volume":"19","author":"Thibaut","year":"2017","journal-title":"Dialogues Clin Neurosci"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.012_bib38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/jsr.12594","article-title":"European guideline for the diagnosis and treatment of insomnia","volume":"26","author":"Riemann","year":"2017","journal-title":"J\u00a0Sleep Res"},{"key":"10.1016\/j.mcna.2021.08.012_bib39","series-title":"Helping patients taper from benzodiazepines","year":"2015"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.012_bib40","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/070674370605100706","article-title":"Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program","volume":"51","author":"Voshaar","year":"2006","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.mcna.2021.08.012_bib41","article-title":"Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users","volume":"3","author":"Baandrup","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.012_bib42","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1176\/ajp.146.4.536","article-title":"Carbamazepine treatment for benzodiazepine withdrawal","volume":"146","author":"Ries","year":"1989","journal-title":"Am J Psychiatry"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.012_bib43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/2045125317753340","article-title":"Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation","volume":"8","author":"Fluyau","year":"2018","journal-title":"Ther Adv Psychopharmacol"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.012_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0269881111405360","article-title":"Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial","volume":"26","author":"Hadley","year":"2012","journal-title":"J\u00a0Psychopharmacol"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2146\/ajhp160712","article-title":"Pregabalin as adjunctive therapy in benzodiazepine discontinuation","volume":"75","author":"Caniff","year":"2018","journal-title":"Am J Health Syst Pharm"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.012_bib46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/00952990.2015.1125493","article-title":"Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients","volume":"42","author":"Mariani","year":"2016","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/09595230100100615","article-title":"In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods","volume":"22","author":"McGregor","year":"2003","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.012_bib48","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jsat.2011.12.011","article-title":"Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification","volume":"43","author":"Kawasaki","year":"2012","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.mcna.2021.08.012_bib49","article-title":"Psychosocial interventions for benzodiazepine harmful use, abuse or dependence","volume":"5","author":"Darker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.012_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/M14-2841","article-title":"Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis","volume":"163","author":"Trauer","year":"2015","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.012_bib51","article-title":"Motivational interviewing for substance abuse","author":"Smedslund","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib52","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1360-0443.2006.01311.x","article-title":"A\u00a0meta-analysis of voucher-based reinforcement therapy for substance use disorders","volume":"101","author":"Lussier","year":"2006","journal-title":"Addiction"},{"issue":"5","key":"10.1016\/j.mcna.2021.08.012_bib53","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000506868","article-title":"Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications","volume":"89","author":"Cosci","year":"2020","journal-title":"Psychother Psychosom"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.012_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/1381612023396654","article-title":"Cognitive and sedative effects of benzodiazepine use","volume":"8","author":"Buffett-Jerrott","year":"2002","journal-title":"Curr Pharm Des"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.012_bib55","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and Z-drugs: an updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs R D"},{"issue":"8","key":"10.1016\/j.mcna.2021.08.012_bib56","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2165\/11533170-000000000-00000","article-title":"The relationship between benzodiazepine use and traffic accidents: a systematic literature review","volume":"24","author":"Smink","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1016\/j.mcna.2021.08.012_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.maturitas.2017.04.002","article-title":"Relationship between the use of benzodiazepines and falls in older adults: a systematic review","volume":"101","author":"D\u00edaz-Guti\u00e9rrez","year":"2017","journal-title":"Maturitas"},{"issue":"14","key":"10.1016\/j.mcna.2021.08.012_bib58","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1001\/archinte.164.14.1567","article-title":"Benzodiazepine use and hip fractures in the elderly: who is at greatest risk?","volume":"164","author":"Wagner","year":"2004","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.mcna.2021.08.012_bib59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American Geriatrics Society 2019 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib60","doi-asserted-by":"crossref","first-page":"16r02037","DOI":"10.4088\/PCC.16r02037","article-title":"Prescribed benzodiazepines and suicide risk: a review of the literature","volume":"19","author":"Dodds","year":"2017","journal-title":"Prim Care Companion CNS Disord"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.012_bib61","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12888-019-2312-3","article-title":"Association between benzodiazepines and suicide risk: a matched case-control study","volume":"19","author":"Cato","year":"2019","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.012_bib62","doi-asserted-by":"crossref","first-page":"17m12038","DOI":"10.4088\/JCP.17m12038","article-title":"Benzodiazepines, health care utilization, and suicidal behavior in veterans with posttraumatic stress disorder","volume":"79","author":"Deka","year":"2018","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"6","key":"10.1016\/j.mcna.2021.08.012_bib63","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/10826084.2019.1708118","article-title":"Patterns of polysubstance use among adults with tranquilizer misuse","volume":"55","author":"Votaw","year":"2020","journal-title":"Subst Use Misuse"},{"issue":"2S Suppl 1","key":"10.1016\/j.mcna.2021.08.012_bib64","first-page":"1","article-title":"The ASAM national practice guideline for the treatment of opioid use disorder: 2020 focused update","volume":"14","year":"2020","journal-title":"J Addict Med"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.012_bib65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1521-0391.2009.00007.x","article-title":"Benzodiazepines, methadone and buprenorphine: interactions and clinical management","volume":"19","author":"Lintzeris","year":"2010","journal-title":"Am J Addict"},{"key":"10.1016\/j.mcna.2021.08.012_bib66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2016.06.008","article-title":"Reasons for benzodiazepine use among persons seeking opioid detoxification","volume":"68","author":"Stein","year":"2016","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.mcna.2021.08.012_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.drugpo.2017.05.016","article-title":"High enhancer, downer, withdrawal helper: multifunctional nonmedical benzodiazepine use among young adult opioid users in New York City","volume":"46","author":"Mateu-Gelabert","year":"2017","journal-title":"Int J Drug Policy"},{"issue":"2","key":"10.1016\/j.mcna.2021.08.012_bib68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.amepre.2016.02.014","article-title":"Trends in the concomitant prescribing of opioids and benzodiazepines, 2002-2014","volume":"51","author":"Hwang","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.mcna.2021.08.012_bib69","doi-asserted-by":"crossref","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.mcna.2021.08.012_bib70","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1176\/appi.ajp.2020.20081174","article-title":"Association between benzodiazepine or Z-drug prescriptions and drug-related poisonings among patients receiving buprenorphine maintenance: a case-crossover analysis","volume":"178","author":"Xu","year":"2021","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.mcna.2021.08.012_bib71","series-title":"FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use","year":"2016"},{"issue":"3","key":"10.1016\/j.mcna.2021.08.012_bib72","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.amepre.2020.09.007","article-title":"Trends in co-prescribing of opioids and opioid potentiators among U.S. adults, 2007-2018","volume":"60","author":"Rhee","year":"2021","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.mcna.2021.08.012_bib73","series-title":"FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks","year":"2017"},{"key":"10.1016\/j.mcna.2021.08.012_bib74","series-title":"The TEDS report: admissions reporting benzodiazepine and narcotic pain reliever abuse at treatment entry","year":"2012"},{"issue":"1","key":"10.1016\/j.mcna.2021.08.012_bib75","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.drugalcdep.2004.04.002","article-title":"Benzodiazepine co-dependence exacerbates the opiate withdrawal syndrome","volume":"76","author":"de Wet","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.mcna.2021.08.012_bib76","doi-asserted-by":"crossref","first-page":"108455","DOI":"10.1016\/j.jsat.2021.108455","article-title":"\u201cIt could potentially be dangerous... but nothing else has seemed to help me.\u201d: patient and clinician perspectives on benzodiazepine use in opioid agonist treatment","volume":"131","author":"Park","year":"2021","journal-title":"J\u00a0Subst Abuse Treat"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521001206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712521001206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,12,29]],"date-time":"2022-12-29T19:44:11Z","timestamp":1672343051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712521001206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0025712521001206"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2021.08.012","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benzodiazepines and Related Sedatives","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2021.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}